Abstract
Purpose
To investigate the correlation between foveal photoreceptor integrity and final visual acuity (VA) after treatment of eyes with diabetic macular edema (DME), and to determine the visual prognostic factors.
Methods
We retrospectively studied 61 eyes of 52 patients with DME who were treated successfully with intravitreal triamcinolone injection (IVTA). Using spectral domain optical coherence tomography (SD-OCT), the eyes were categorized into three groups at the final visit according to restoration of the photoreceptor inner and outer segment junction (IS/OS) and the external limiting membrane (ELM): (1) the A group, with a completely visible IS/OS and ELM, (2) the B group, with a disrupted IS/OS and intact ELM, and (3) the C group, with a disrupted or loss of the IS/OS and ELM. Disrupted IS/OS length (DIL), disrupted ELM length (DEL), and mean disrupted IS/OS and ELM length (DIEL) were measured at the initial and final visits. Foveal thickness (FT), macular center thickness (MCT), and outer nuclear layer (ONL) thickness were also measured at the initial and final visits. Multivariate analysis testing was performed over the measured SD OCT variables.
Results
Final VA was closely associated with IS/OS integrity at the final visit; final VA (logMAR) in the A group (0.21 ± 0.14; 31 eyes) or B group (0.31 ± 0.21; 15 eyes) was significantly better than that in the C group (0.45 ± 0.33; 15 eyes) (p < 0.001). Shorter DIL, DEL, and DIEL at the final visit were associated with better final VA. Multivariate analysis showed that DIEL (r = 0.564) have the greatest correlation coefficient with final VA compared to DIL (r = 0.561) and DEL (r = 0.540). Better VA, preservation of the IS/OS and ELM at the initial visit were associated with intact photoreceptor integrity after resolution of DME. However, MCT, FT, and ONL thickness had no significant correlation with photoreceptor integrity.
Conclusion
IS/OS and ELM are useful hallmarks for use in evaluation of foveal photoreceptor layer integrity, and are closely associated with final VA in DME. Pretreatment VA and photoreceptor status can predict potential restoration of photoreceptor integrity and subsequent visual recovery in DME.
Similar content being viewed by others
References
Klein R, Klein BE, Moss SE, Linton KL (1992) Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 99:58–62
Brensick GH (1983) A critical review highlighting diffuse macular edema. Ophthalmology 90:1301–1317
Mcdonald HR, Schatz H (1985) Grid photocoagulation for diffuse macular edema. Retina 5:65–72
Olk RJ (1986) Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 93:938–950
Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99:753–759
Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121:405–413
Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122:258–260
Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A (2006) Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26:999–1005
Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, Berrocal MH, Solis-Vivanco A, Farah ME, Pan-American Collaborative Retina Study Group (2007) Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 114:743–750
Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927
Avitabile T, Longo A, Reibaldi A (2005) Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoids macular edema. Am J Ophthalmol 140:695–702
Sakamoto A, Nishijima K, Kita M, Oh H, Tsujikawa A, Yoshimura N (2009) Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 247:1325–1330
Hangai M, Ojima Y, Yoshida A, Yasuno Y, Makita S, Yatagai T, Yoshimura N (2007) Improved visualization of foveal pathologies using Fourier-domain optical coherence tomography. Nippon Ganka Gakkai Zasshi 111:509–517
Hangai M, Ojima Y, Gotoh N, Inoue R, Yasuno Y, Makita S, Yamanari M, Yatagai T, Kita M, Yoshimura N (2007) Three-dimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology 114:763–773
Sakamoto A, Tsujikawa A, Ota M, Yamaike N, Kotera Y, Miyamoto K, Kita M, Yoshimura N (2009) Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion. Clin Exp Ophthalmol 37:208–216
Ota M, Tsujikawa A, Murakami T, Kita M, Miyamoto K, Sakamoto A, Yamaike N, Yoshimura N (2007) Association between integrity of foveal photoreceptor layer and visual acuity in branched retinal vein occlusion. Br J Ophthalmol 91:1644–1649
Ota M, Tsujikawa A, Kita M, Miyamoto K, Sakamoto A, Yamaike N, Kotera Y, Yoshimura N (2008) Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina 28:1502–1508
Hayashi H, Yamashiro K, Tsujikawa A, Ota M, Otani A, Yoshimura N (2009) Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol 148:83–89
Sayanagi K, Sharma S, Kaiser PK (2009) Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 93:622–626
Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87–99
Eandi DM, Chung JE, Cardillo-Piccolino F, Spaide RF (2005) Optical coherence tomography in unilateral resolved central serous chorioretinopathy. Retina 25:417–421
Yamaike N, Tsujikawa A, Ota M, Sakamoto A, Kotera Y, Kita M, Miyamoto K, Yoshimura N, Hangai M (2008) Three-dimensional imaging of cystoids macular edema in retinal vein occlusion. Ophthalmology 115:355–362
Oishi A, Hata M, Shimozono M, Mandai M, Nishida A, Kurimoto Y (2010) The significance of external limiting membrane status for visual acuity in age-related macular degeneration. Am J Ophthalmol 150:27–32
Wakabayashi T, Oshima Y, Fujimoto H, Murakami Y, Sakaguchi H, Kusaka S, Tano Y (2009) Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology 116:519–528
Maheshwary AS, Oster SF, Ritchie M, Yuson RM, Cheng L, Mojana F, Freeman WR (2010) The association between percent disruption of the photoreceptor inner segment–outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol 150:63–67
Otani T, Yamaguchi Y, Kishi S (2010) Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 30:774–780
Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57–61
Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S (2004) Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88:1131–1136
Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A (2004) Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111:218–224
Quinlan PM, Elman MJ, Bhatt AK, Mardesich P, Enger C (1990) The natural course of central retinal vein occlusion. Am J Ophthalmol 110:118–123
Subramanian ML, Heier JS, Esrick E, Devaiah AK, Topping TM, Frederick AR, Morley MG (2006) Preoperative visual acuity as a prognostic indication for laser treatment of macular edema due to branch retinal vein occlusion. Ophthalmic Surg Laser Imaging 37:462–467
Hirami Y, Mandai M, Takahashi M, Teramukai S, Tada H, Yoshimura N (2009) Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration. Jpn J Ophthalmol 53:396–407
Kwon SI, Ko SJ, Park IW (2009) The clinical course of the idiopathic epiretinal membrane after surgery. Korean J Ophthalmol 23:249–252
Matsumoto H, Sato T, Kishi S (2009) Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. Am J Ophthalmol 148:105–110
Marshall J, Hamilton AM, Bird AC (1975) Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. Br J Ophthalmol 59:610–630
Zacks DN, Ezra E, Terada Y, Michaud N, Connolly E, Gragoudas ES, Miller JW (2002) Verteporfin photodynamic terapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. Invest Ophthalmol Vis Sci 43:2384–2391
Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW (1999) Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 106:1915–1923
Wakabayashi T, Fujiwara M, Sakaguchi H, Kusaka S, Oshima Y (2010) Foveal microstructural and visual acuity in surgically closed macular hole: spectral domain optical coherence tomographic analysis. Ophthalmology 117:1815–1824
Wolf-Schnurrbusch UE, Ghanem R, Rothenbuehler SP, Enzmann V, Framme C, Wolf S (2011) Predictors of short term outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. Invest Ophthalmol Vis Sci 52(6):3334–3337
Massin P, Duguid G, Erginay A, Haouchine B, Gaudric A (2003) Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 135:169–177
Deak GG, Bolz M, Ritter M, Prager S, Benesch T, Schmidt-Erfurth U, Diabetic Retinopathy Research Group Vienna (2010) A systematic correlation between morphology and functional alterations in diabetic macular edema. Invest Ophthalmol Vis Sci 51:6710–6714
Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20:126–133
Kaiser P, Riemann C, Sears J, Lewis H (2001) Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 131:44–49
Han IC, Jaffe GJ (2010) Evaluation of artifacts associated with macular spectral-domain optical coherence Tomography. Ophthalmology 117:1177–1189
Dale EA, Hood DC, Greenstein VC, Odel JG (2010) A comparison of multifocal ERG and frequency domain OCT changes in patients with abnormalities of the retina. Doc Ophthalmol 120:175–186
Conflict of interest
The authors have no financial interest in any aspect of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shin, H.J., Lee, S.H., Chung, H. et al. Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 250, 61–70 (2012). https://doi.org/10.1007/s00417-011-1774-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-011-1774-x